“Whether and How the U.S. Government Should Exercise Its Compulsory Licensing Authority Under 28 U.S.C. § 1498 and the Bayh-Dole Act”

  • Intellectual Property and Antitrust
New York University Journal of Intellectual Property and Entertainment Law
2021

“A Functional Approach to Judicial Review of PTAB Rulings on Mixed Questions of Law and Fact”

  • Intellectual Property and Antitrust
Iowa Law Review
2019

“Opting Into Device Regulation in the Face of Uncertain Patentability”

  • Intellectual Property and Antitrust
  • Law and Technology
Marquette Intellectual Property Law Review
2019

“Anticommons, Transaction Costs, and Patent Aggregators”

  • Intellectual Property and Antitrust
Research Handbook on the Economics of Intellectual Property Law
2019

“Intellectual Property and Public Health”

  • Intellectual Property and Antitrust
  • Health Law
Oxford Handbook of Intellectual Property Law
2018

“Universities: The Fallen Angels of Bayh-Dole?”

  • Intellectual Property and Antitrust
Daedalus
2018

“Promoting Healthcare Innovation on the Demand Side”

  • Intellectual Property and Antitrust
  • Law and Technology
Journal of Law and the Biosciences
2017

“Diagnostics Need Not Apply”

  • Intellectual Property and Antitrust
  • Law and Technology
Boston University Journal of Science & Technology Law
2015

“Patent Punting: How FDA and Antitrust Courts Undermine the Hatch-Waxman Act to Avoid Dealing with Patents”

  • Intellectual Property and Antitrust
Michigan Telecommunications and Technology Law Review
2015

“Prometheus Rebound: Diagnostics, Nature, and Mathematical Algorithms”

  • Intellectual Property and Antitrust
Yale Law Journal Online
2013

“Wisdom of the Ages or Dead-Hand Control? Patentable Subject Matter for Diagnostic Methods After In Re Bilski”

  • Intellectual Property and Antitrust
Case Western Reserve Journal of Law, Technology & the Internet
2012

“Patents and Regulatory Exclusivity”

  • Intellectual Property and Antitrust
The Oxford Handbook of the Economics of the Biopharmaceutical Industry
2012

“Data Secrecy in the Age of Regulatory Exclusivity”

  • Intellectual Property and Antitrust
The Law and Theory of Trade Secrecy: A Handbook of Contemporary Research
2011

“Patent Costs and Unlicensed Use of Patented Inventions”

  • Intellectual Property and Antitrust
University of Chicago Law Review
2011

“Costs, Norms, and Inertia: Avoiding an Anticommons for Proprietary Research Tools”

  • Intellectual Property and Antitrust
Working Within the Boundaries of Intellectual Property: Innovation Policy for the Knowledge Society
2010

“One Size Fits All, After Tailoring”

  • Intellectual Property and Antitrust
Science
2009

“Patents and the Progress of Science: Exclusive Rights and Experimental Use”

  • Intellectual Property and Antitrust
The Economics of Innovation Policy
2008

“Pharma’s Nonobvious Problem”

  • Intellectual Property and Antitrust
Lewis and Clark Law Review
2008

“Noncompliance, Nonenforcement, Nonproblem? Rethinking the Anticommons in Biomedical Research”

  • Intellectual Property and Antitrust
Houston Law Review
2008

“The Supreme Court and the Federal Circuit: Visitation and Custody of Patent Law”

  • Intellectual Property and Antitrust
Michigan Law Review First Impressions
2007

“The Role of the FDA in Innovation Policy”

  • Intellectual Property and Antitrust
Michigan Telecommunications and Technology Law Review
2007

“Harnessing and Sharing the Benefits of State-Sponsored Research: Intellectual Property Rights and Data Sharing in California’s Stem Cell Initiative”

  • Intellectual Property and Antitrust
Berkeley Technology Law Journal
2006

“BioTech. Patents: Looking Backward While Moving Forward”

  • Intellectual Property and Antitrust
Nature Biotechnology
2006

“The Story of Diamond v. Chakrabarty: Technological Change and the Subject Matter Boundaries of the Patent System”

  • Intellectual Property and Antitrust
Intellectual Property Stories
2006

“Patents and Data-Sharing in Public Science”

  • Intellectual Property and Antitrust
Industrial and Corporate Change
2006

“How Can You Patent Genes?”

  • Intellectual Property and Antitrust
Genetics: Science, Ethics and Public Policy: A Reader
2005

“Obvious to Whom? Evaluating Inventions from the Perspective of PHOSITA”

  • Intellectual Property and Antitrust
Berkeley Technology Law Journal
2004

“Patenting Genome Research Tools and the Law”

  • Intellectual Property and Antitrust
Comptes rendus Biologies
2003

“Patent Swords and Shields”

  • Intellectual Property and Antitrust
Science
2003

“Reaching Through the Genome”

  • Intellectual Property and Antitrust
Perspectives on Properties of the Human Genome Project
2003

“Can Patents Deter Innovation? The Anticommons in Biomedical Research”

  • Intellectual Property and Antitrust
Rights and Resources
2003

“Patents, Product Exclusivity, and Information Dissemination: How Law Directs Biopharmaceutical Research and Development”

  • Intellectual Property and Antitrust
Fordham Law Review
2003

“Bayh-Dole Reform and the Progress of Biomedicine”

  • Intellectual Property and Antitrust
Law and Contemporary Problems
2003

“Bayh-Dole Reform and the Progress of Biomedicine”

  • Intellectual Property and Antitrust
American Scientist
2003

“Patents on DNA Sequences: Molecules and Information”

  • Intellectual Property and Antitrust
The Commodification of Information
2002

“The Role of Patents in Exploiting the Genome”

  • Intellectual Property and Antitrust
The Genomic Revolution: Unveiling the Unity of Life
2002

“How Can You Patent Genes?”

  • Intellectual Property and Antitrust
Who Owns Life?
2002

“How Can You Patent Genes?”

  • Intellectual Property and Antitrust
American Journal of Bioethics
2002

“Public vs. Proprietary Science: A Fruitful Tension?”

  • Intellectual Property and Antitrust
Academic Medicine: Journal of the Association of American Medical Colleges
2002

“Can Patents Deter Innovation? The Anticommons in Biomedical Research”

  • Intellectual Property and Antitrust
Perspectives on Property Law
2002

“Why the Gene Patenting Controversy Persists”

  • Intellectual Property and Antitrust
Academic Medicine: Journal of the Association of American Medical Colleges
2002

“Public vs. Proprietary Science: A Fruitful Tension?”

  • Intellectual Property and Antitrust
Daedalus
2002

“The Shifting Functional Balance of Patents and Drug Regulation”

  • Intellectual Property and Antitrust
Health Affairs
2001

“Bargaining Over the Transfer of Proprietary Research Tools: Is This Market Failing or Emerging?”

  • Intellectual Property and Antitrust
Expanding the Boundaries of Intellectual Property: Innovation Policy for the Knowledge Society
2001

“Analyze This: A Law and Economics Agenda for the Patent System”

  • Intellectual Property and Antitrust
Vanderbilt Law Review
2000

“Ownership, Commercial Development, Transfer and Use of Publicly Funded Research Results: The United States Legal Regime”

  • Intellectual Property and Antitrust
The Role of Publicly Funded Research and Publicly Owned Technologies in the Transfer and Diffusion of Environmentally Sound Technologies
2000

“Re-Examining the Role of Patents in Appropriating the Value of DNA Sequences”

  • Intellectual Property and Antitrust
Emory Law Journal
2000

“Genomics in the Public Domain: Strategy and Policy”

  • Intellectual Property and Antitrust
Nature Reviews Genetics
2000

“Proprietary Rights and the Norms of Science in Biotechnology Research”

  • Intellectual Property and Antitrust
The Economics of Science and Innovation
2000

“The Promise and Perils of Strategic Publication to Create Prior Art: A Response to Professor Parchomovsky”

  • Intellectual Property and Antitrust
Michigan Law Review
2000